MusclePharm Előre P/E
Mi az MusclePharm Előre P/E?
A Előre P/E az MusclePharm Corp. - -0.74
Mi a Előre P/E meghatározása?
Az előrejelzett ár / jövedelem arány a vállalat tőzsdei árának és a társaság becsült részvényenkénti eredményének aránya a következő tizenkét hónapban.
The forward price to earnings ratio is similar to trailing price to earnings ratio but instead of net income uses estimated net earnings over next 12 months. Estimates are typically derived as the mean of those published by a select group of analysts with selection criteria varying. The forward price-to-earnings ratio is a powerful, but limited tool. It allows a quick snapshot of the company’s finances without getting down in the details of an accounting report.
Előre P/E a Consumer Staples szektor a OTC-on cégekben a MusclePharm -hoz képest
Mit csinál MusclePharm?
MusclePharm Corporation develops, manufactures, markets, and distributes sports nutrition products and nutritional supplements in the United States and internationally. The company offers a range of performance powders, capsules, tablets, gels, and on-the-go ready to eat snacks. Its MusclePharm brand product portfolio includes combat protein powder and combat crunch protein bars; and essential supplements, such as a BCAA, creatine, glutamine, carnitine, CLA, fish oil, multi-vitamin, and other products. The company also provides FitMiss branded sports nutrition products, which are formulated primarily for the female body to support women in the areas of weight management, lean muscle mass, body composition, and general health and wellness; and functional energy beverages under the Combat Energy and FitMiss Energy brands. It sells its products to various athletes and fitness enthusiasts. The company was incorporated in 2006 and is based in Las Vegas, Nevada.
előre p/e -hoz hasonló cégek MusclePharm
- Energous Corp nak Előre P/E -0.77 van
- Interpace Biosciences Inc nak Előre P/E -0.76 van
- Milestone Pharmaceuticals Inc nak Előre P/E -0.76 van
- Sonnet BioTherapeutics Inc nak Előre P/E -0.75 van
- Aspen Inc nak Előre P/E -0.75 van
- Aclaris Therapeutics Inc nak Előre P/E -0.74 van
- MusclePharm nak Előre P/E -0.74 van
- Karyopharm Therapeutics Inc nak Előre P/E -0.73 van
- Cellectar Biosciences Inc nak Előre P/E -0.73 van
- Surface Oncology Inc nak Előre P/E -0.73 van
- Mersana Therapeutics Inc nak Előre P/E -0.72 van
- MJardin nak Előre P/E -0.71 van
- FibroGen Inc nak Előre P/E -0.70 van